Schedule 13G ownership disclosure
Immuneering Corp
Class A common stock, par value $0.001 per share · CUSIP: 45254E107
Event date: 2025-12-31
- Filing-level shares
- 4,357,807.00
- Percent of class
- 6.6%
- BENJAMIN J. ZESKIND
Shares: 4,357,807.00 · Class: 6.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001790340-26-000020
- Form type
- SCHEDULE 13G/A
- Filer
- Immuneering Corp
- CIK
- CIK 1790340
- Filed
- Jan 22, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership